• SENSEX
    NIFTY 50
Business

Cipla remains confident after US FDA observations, says de-risking plan in place 

Updated : October 11, 2019 03:58 PM IST

According to the company, the observations mainly centered on facilities, equipment and infrastructure. 
The share price fell up to 7.74 percent to touch its five-year low of Rs 389.6 on the NSE after the US regulator issued 12 observations to the plant.
Cipla remains confident after US FDA observations, says de-risking plan in place 
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more

You May Also Like

Live TV